U.S. Secretary of State Mike Pompeo said in a television interview on Wednesday that China’s treatment of Muslims, including the Uighurs, in western China was an “enormous human rights violation” and Washington will continue to raise the issue.
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients’ money after undertaking a rigorous examination of any potential stock. They are particularly successful in this regard when it comes to small-cap stocks, which their peerless research gives them a big information advantage on when it comes to judging their worth. […] …read more […]
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile […] …read more […]
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018. Trends reversed 180 degrees during the first half of 2019 amid Powell’s pivot and optimistic expectations towards a trade deal with China. Hedge funds and institutional investors tracked by Insider Monkey usually invest a […] …read more […]
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we’ve gathered as a result gives us access to a wealth of collective knowledge based on these firms’ portfolio holdings as of June 28. In this […] …read more […]
The judge overseeing the bankruptcy of PG&E Corp on Wednesday issued an order opening the door to a group of noteholders and wildfire victims to file their own reorganization plan for the California power provider.
Is Altria Group Inc (NYSE:MO) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, and get tips from investment bankers and industry insiders. Sure they sometimes fail miserably, but their consensus stock picks […] …read more […]
How do we determine whether General Motors Company (NYSE:GM) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend immense amounts of time and resources studying companies. They may not always be right (no one is), but data shows […] …read more […]
U.S. stock futures tumbled and the safe haven yen and the Swiss franc gained in early Asian trade on Thursday after a media report that the United States and China had made no progress in deputy-level trade talks earlier in the week.
U.S. stock futures tumbled and the safe haven yen and the Swiss franc gained in early Asian trade on Thursday after a media report that the United States and China had made no progress in deputy-level trade talks earlier in the week. The South China Morning Post also said the Chinese delegation, headed by Vice Premier Liu He, is planning to leave Washington on Thursday after just one day of minister-level meetings, instead of an originally planned departure set for Friday. In the currency market, the yen advanced 0.3% to 107.11 to the dollar while the Swiss franc …read more […]
Oilfield services firm ProPetro Holding Corp on Wednesday shuffled its top executives amid an internal investigation into equipment purchases and expense reimbursements.
Australian drugmaker Clinuvel Pharmaceuticals Ltd said on Wednesday the pricing of its recently approved treatment for a rare genetic disorder in the United States will not top its price in Europe. The drug, Scenesse, was approved by the U.S. Food and Drug Administration on Tuesday to treat erythropoietic protoporphyria (EPP), a painful disorder that causes the skin to itch, burn, and scar in some rare cases, when exposed to sunlight and some types of artificial light. Scenesse is available in Europe since 2014, where its price ranges between 70,000 euros ($76,811.00) and 100,000 euros ($109,730.00) per patient …read more […]
U.S. stock futures tumbled and the safe haven yen and the Swiss franc gained in early Asian trade on Thursday after a media report that the United States and China had made no progress in deputy-level trade talks earlier in the week. The South China Morning Post also said the Chinese delegation, headed by Vice Premier Liu He, is planning to leave Washington on Thursday after just one day of minister-level meetings, instead of an originally planned departure set for Friday. In the currency market, the yen advanced 0.3% to 107.11 to the dollar while the Swiss franc …read more […]
The United States and China made no progress in deputy-level trade talks held during Monday and Tuesday in Washington, the South China Morning Post (SCMP) reported, citing unnamed sources with knowledge of the meetings.
A jury award that hit Johnson & Johnson with $8 billion in punitive damages for a case involving its anti-psychotic drug Risperdal highlights the risks of the drugmaker’s all-or-nothing legal strategy, several legal experts told Reuters on Wednesday.
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
